$38.0M
The financing round brings the total capital raised by the Paris based company to $100m.
A
Aqemia
Aqemia builds an artificial intelligence platform for drug discovery using atomic scale physics.
Paris, France—Founded 2024
$38.0MTotal raised
Aqemia develops an artificial intelligence platform for drug discovery that uses atomic scale physics rather than experimental training data. The Paris based company focuses on creating novel molecular structures for pharmaceutical applications.
Categories
Founders
ML
Maximilien Levesque
CEO and co-founder